Literature DB >> 12756353

Quality of life in patients with chronic venous disease: San Diego population study.

Robert M Kaplan1, Michael H Criqui, Julie O Denenberg, John Bergan, Arnost Fronek.   

Abstract

BACKGROUND: Chronic venous disease in the lower extremities may have a substantial effect on functioning and quality of life. We report quality of life data for an ethnically diverse population that had been systematically evaluated for venous disease.
SUBJECTS: Current and retired employees from a large public university were randomly selected within strata of age, sex, and ethnicity. The sample included 2404 men and women ages 40 to 79 years. MEASURES: Quality of life was measured with the Medical Outcomes Study 36-Item Short Form (SF-36). Venous disease of the lower extremities was evaluated with two methods. Visual inspection was used to place participants into four categories: normal, telangiectasias and spider veins, varicose veins, and trophic changes. Duplex ultrasound scanning was used to place participants into three categories: normal, superficial venous disease, and deep vein disease.
RESULTS: There were significant associations between quality of life and venous disease severity as assessed with both visual and ultrasound methods. These differences were observed for both men and women for functional scales of the SF-36. The relationships were significant, and were graded with degree of disease severity. Differences categories were not statistically significant for the mental health scales of the SF-36.
CONCLUSION: Chronic venous disease in the lower extremities has a substantial effect on physical health aspects of quality of life but not on mental health components.

Entities:  

Mesh:

Year:  2003        PMID: 12756353     DOI: 10.1067/mva.2003.168

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  43 in total

1.  Acute venous occlusion enhances matrix metalloprotease activity: Implications on endothelial dysfunction.

Authors:  Tom Alsaigh; Elizabeth S Pocock; John J Bergan; Geert W Schmid-Schönbein
Journal:  Microvasc Res       Date:  2010-10-16       Impact factor: 3.514

2.  Psychological impact of thrombosis in the young.

Authors:  Diletta Fiandaca; Paolo Bucciarelli; Ida Martinelli; Francesca Tantardini; Carmen Clemente; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 3.  The effect of short saphenous vein stripping in patients with deep venous reflux.

Authors:  Masatoshi Jibiki; Yoshinori Inoue; Hiroaki Terasaki; Kimihiro Igari; Hidetoshi Uchiyama; Mieko Miyai; Tomoko Kagayama
Journal:  Ann Vasc Dis       Date:  2013-07-31

4.  Socio-economic impact of endovenous thermal ablation techniques.

Authors:  Damian Kelleher; Tristan R A Lane; Ian J Franklin; Alun H Davies
Journal:  Lasers Med Sci       Date:  2013-10-05       Impact factor: 3.161

5.  Effect of spatial light distribution on the thermal response of vascular tissue.

Authors:  Van Gia Truong; Van Nam Tran; Jieun Hwang; Hyun Wook Kang
Journal:  Biomed Opt Express       Date:  2018-06-08       Impact factor: 3.732

6.  Age is not a barrier to good outcomes after varicose vein procedures.

Authors:  Danielle C Sutzko; Elizabeth A Andraska; Andrea T Obi; Mikel Sadek; Lowell S Kabnick; Thomas W Wakefield; Nicholas H Osborne
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2017-09

Review 7.  A review of the current management and treatment options for superficial venous insufficiency.

Authors:  Henry T Zhan; Ruth L Bush
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

8.  Current treatment of varicose veins.

Authors:  François Becker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

9.  Endovascular laser therapy for varicose veins: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-04-01

10.  Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.